Literature DB >> 18752087

Quality of life in amyotrophic lateral sclerosis/motor neuron disease: a structured review.

Joanna Epton1, Robert Harris, Crispin Jenkinson.   

Abstract

Amyotrophic lateral sclerosis/motor neuron disease and other related disorders are fatal progressive neurodegenerative conditions that have a substantial impact on quality of life (QoL). This systematic review examines the different methods and instruments used to assess QoL in this condition from which recommendations are made of those that evidence suggests are the most appropriate. Databases were used to survey the available literature to cover as many different approaches and papers as possible. Due to the wide variety of approaches to the measurement of QoL data across the papers, no meta-analysis was possible. The available evidence suggests that at the present time the most appropriate measures are the SF-36, a generic widely used QoL measure, and the disease specific ALSAQ-40. However, as many of the validation studies on the ALSAQ-40 were undertaken by the developers of this instrument, further independent research is desirable to confirm these conclusions.

Entities:  

Mesh:

Year:  2009        PMID: 18752087     DOI: 10.1080/17482960802163721

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  12 in total

Review 1.  Economic Studies in Motor Neurone Disease: A Systematic Methodological Review.

Authors:  Alan Moore; Carolyn A Young; Dyfrig A Hughes
Journal:  Pharmacoeconomics       Date:  2017-04       Impact factor: 4.981

2.  Health-related quality of life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy.

Authors:  Yaroslav Winter; Karsten Schepelmann; Annika E Spottke; Detlef Claus; Christoph Grothe; Rolf Schröder; Dieter Heuss; Stefan Vielhaber; Björn Tackenberg; Veit Mylius; Jens-Peter Reese; Reinhard Kiefer; Bertold Schrank; Wolfgang H Oertel; Richard Dodel
Journal:  J Neurol       Date:  2010-04-10       Impact factor: 4.849

3.  Cross-cultural adaptation and validation for the Brazilian population of the instrument Amyotrophic Lateral Sclerosis-Specific Quality of Life-Short Form (ALSSQOL-SF).

Authors:  Maisa Vitória Gayoso; Flávia Seullner Domingues; Marcondes Cavalcante França Junior; Stephanie H Felgoise; Acary Souza Bulle Oliveira; Guilherme Antonio Moreira de Barros
Journal:  Qual Life Res       Date:  2019-10-29       Impact factor: 4.147

4.  Psychiatric aspects of amyotrophic lateral sclerosis (ALS).

Authors:  Lorenzo Norris; Guinevere Que; Elham Bayat
Journal:  Curr Psychiatry Rep       Date:  2010-06       Impact factor: 5.285

5.  Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology.

Authors:  D Cella; J-S Lai; C J Nowinski; D Victorson; A Peterman; D Miller; F Bethoux; A Heinemann; S Rubin; J E Cavazos; A T Reder; R Sufit; T Simuni; G L Holmes; A Siderowf; V Wojna; R Bode; N McKinney; T Podrabsky; K Wortman; S Choi; R Gershon; N Rothrock; C Moy
Journal:  Neurology       Date:  2012-05-09       Impact factor: 9.910

Review 6.  Diagnostics of Amyotrophic Lateral Sclerosis: Up to Date.

Authors:  Ivana Štětkářová; Edvard Ehler
Journal:  Diagnostics (Basel)       Date:  2021-02-03

7.  Self perceived emotional functioning of spanish patients with amyotrophic lateral sclerosis: a longitudinal study.

Authors:  Jesús S Mora; Teresa Salas; María L Fajardo; Lourdes Iváñez; Francisco Rodríguez-Santos
Journal:  Front Psychol       Date:  2013-01-08

8.  Fatigue and Depression in Iranian Amyotrophic Lateral Sclerosis Patients in Tehran in 2012.

Authors:  Maryam Nazemi; Marjan Hassani Raad; Christineh Serob Arzoomanian; Azizreza Ghasemzadeh
Journal:  Electron Physician       Date:  2016-03-25

Review 9.  Sleep and Sleep Disruption in Amyotrophic Lateral Sclerosis.

Authors:  Matthias Boentert
Journal:  Curr Neurol Neurosci Rep       Date:  2020-05-27       Impact factor: 5.081

10.  Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives.

Authors:  Matthias Boentert
Journal:  Nat Sci Sleep       Date:  2019-08-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.